|
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 Sep 7:S2213-2600(21)00354-4. doi: 10.1016/S2213-2600(21)00354-4. Epub ahead of print. PMID: 34506761.
|
